CONFIRMED SPEAKERS

Nicola Aceto, PhD
Associate Professor of Molecular Oncology, Group Leader of the Molecular Oncology Lab, Institute of Molecular Health Sciences, Department of Biology of the Swiss Federal Institute of Technology (ETH) Zurich, Switzerland

Viktor Adalsteinsson, PhD
Associate Director of the Gerstner Center for Cancer Diagnostics, Broad Institute, Boston, USA

Catherine Alix-Panabières, PhD
Laboratoire Cellules Circulantes Rares Humaines - LCCRH, Institut de Recherche en Biothérapie - IRB , Hôpital Saint-Eloi - CHRU Montpellier, France

Emmanuel S. Antonarakis, MD
Professor of Medicine
University of Minnesota Masonic Cancer Center Minneapolis, Minnesota, USA

Clotilde Costa, PhD
Head of The Liquid Biopsy Line of The Roche-Chus Joint Unit, Santiago de Compostela, Spain

Richard J. Cote, M.D. FRCPath, FCAP
Professor and Incoming Chair, Department of Pathology and Immunology, Pathologist-in-Chief, Barnes-Jewish Hospital, Washinghton University in St Louis, St Louis, USA

Massimo Cristofanilli, MD, FACP
Professor of Medicine, Associate Director of Translational Research and Precision Medicine, Department of Medicine-Hematology and Oncology, Robert H Lurie Comprehensive Cancer Center Feinberg School of Medicine, Chicago, IL, USA

Caroline Dive, PhD
Professor, Deputy Director Cancer Research UK Manchester Institute, Senior Group Leader Clinical & Experimental Pharmacology, The University of Manchester, UK

Helen Heitzer, PhD
Institute of Human Genetics, Diagnostic and Research Center for Molecular BioMedicine, Medical University of Graz, Graz, Austria

Michail Ignatiadis, MD PhD
Assoc. Professor, Université Libre de Bruxelles, Jules Bordet Institute Brussels, Belgium, Chair Breast Cancer Group EORTC

Wolfgang Janni, MD PhD
Medical Director of the Gynaecological University Hospital Ulm, University of Ulm, Germany

Raghu Kalluri, MD, PhD
Department of Cancer Biology, Metastasis Research Center, University of Texas MD Anderson Cancer Center, Houston, TX, USA

Yibin Kang, PhD
Warner-Lambert/Parke-Davis Professor of Molecular Biology, Princeton University, Princeton, New Jersey, USA

Sabine Kasimir-Bauer, PhD
Professor, Head of Laboratory, Dep. of Gynecology and Obstetrics, University Hospital of Essen, Germany

Evi Lianidou, PhD
Professor of Analytical Chemistry – Clinical Chemistry, Analysis of Circulating Tumor Cells lab, Dept of Chemistry, University of Athens, Greece

Mike Makrigiorgos, PhD
Professor and Director, Medical Physics and Biophysics, Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA

Stuart S. Martin, PhD
Professor of Translational Cancer Research, University of Maryland School of Medicine, USA

Klaus Pantel, MD, PhD
Professor, Director, Institute of Tumour Biology, Centre of Experimental Medicine, University Medical Centre Hamburg Eppendorf, Hamburg, Germany

Nicholas Papadopoulos, PhD
Professor of Oncology and Pathology, Director of Translational Genetics, Ludwig Center for Cancer Genetics and Therapeutics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, USA

Jean-Yves Pierga, MD, PhD
Professor of Medical Oncology, at the Institute Curie and University Paris Descartes, Paris, France

Amanda Psyrri, MD, PhD
Professor, University of Athens Medical School, Attikon University Hospital, Athens, Greece

Howard Scher, MD
Medical Oncologist, Co-Chair, Center for Mechanism Based Therapy; Head of the Biomarker Development Initiative; D. Wayne Calloway Chair in Urologic Oncology, Memorial Sloan Kettering Cancer Research, New York, NY, USA

Nikolas Stoecklein, MD
Professor, Experimental Surgical Oncology, Heinrich Heine University, Düsseldorf, Germany

Leon Terstappen, MD, PhD
Professor, Faculty of Science and
Technology, TechMed Centre, Department of Medical Cell BioPhysics,
University of Twente, the Netherlands

Jean Paul Thiery, PhD
Senior Scientist and Professor, Guangzhou Regenerative Medicine and Health, Guangdong Laboratory, Visiting Professor, Department of Clinical Medicine, Faculty of Medicine and Dentistry, The University of Bergen, Norway, Research Director CNRS Emeritus, CNRS UMR 7057, Matter and Complex Systems, University Paris Denis Diderot, Paris, France, Research Director Emeritus, Comprehensive Cancer Center Institut Gustave Roussy, Villejuif, France

Andreas Trumpp, PhD
Head, Division of Stem Cells and Cancer at the German Cancer Research Center (DKFZ), Heidelberg, Germany

Danny R. Welch, PhD
Professor, Department of Cancer Biology, The Kansas University Medical Center, USA